Interest Expense in USD of Mersana Therapeutics, Inc. from 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Mersana Therapeutics, Inc. quarterly/annual Interest Expense history and change rate from 2018 to Q1 2024.
  • Mersana Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $1M, a 1.93% increase year-over-year.
  • Mersana Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $4.09M, a 14.1% increase year-over-year.
  • Mersana Therapeutics, Inc. annual Interest Expense for 2023 was $4.07M, a 22.4% increase from 2022.
  • Mersana Therapeutics, Inc. annual Interest Expense for 2022 was $3.33M, a 163% increase from 2021.
  • Mersana Therapeutics, Inc. annual Interest Expense for 2021 was $1.27M, a 253% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

Mersana Therapeutics, Inc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $4.09M $1M +$19K +1.93% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $4.07M $1.05M +$84K +8.71% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $3.99M $1.02M +$137K +15.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $3.85M $1.03M +$265K +34.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $3.59M $983K +$259K +35.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $3.33M $964K -$17K -1.73% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $3.35M $880K +$782K +798% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $2.56M $760K +$665K +700% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $1.9M $724K +$631K +678% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $1.27M $981K +$889K +966% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $378K $98K +$6K +6.52% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $372K $95K +$8K +9.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $364K $93K +$5K +5.68% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $359K $92K +$5K +5.75% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-26
Q3 2020 $354K $92K -$15K -14% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $369K $87K +$47K +118% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $322K $88K +$88K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $234K $87K Oct 1, 2019 Dec 31, 2019 10-K 2021-02-26
Q3 2019 $107K Jul 1, 2019 Sep 30, 2019 10-K 2021-02-26
Q2 2019 $40K Apr 1, 2019 Jun 30, 2019 10-K 2021-02-26
Q1 2019 $0 Jan 1, 2019 Mar 31, 2019 10-K 2021-02-26

Mersana Therapeutics, Inc. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.07M +$745K +22.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $3.33M +$2.06M +163% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $1.27M +$908K +253% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $359K +$125K +53.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $234K +$234K Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $0 Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.